TRAZITILINE
UNII 7I6MS3VHQE

Substance Identification & Data

This profile provides standardized clinical and technical data for Trazitiline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7I6MS3VHQE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 26070-23-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7I6MS3VHQE

CAS Registry Number

26070-23-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TRAZITILINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H24N2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MXZCHCNRTUYWKE-OQIWPSSASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66617

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

3084449

Unique identification number in the NCBI database of chemical substances.

INN ID

2893

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@]12(c3c([C@@H](c4c1cccc4)CC2)cccc3)N5CCN(C)CC5

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trazitiline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.